6505--Intent to Sole Source - Amyloid Florbetaben Injections
Closed Special Notice Posted
- Solicitation number
- 36C24824Q1585
- Agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) has issued a Special Notice indicating its intent to award a sole source, firm fixed price contract to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. The estimated value of the contract is approximately $110,000 per year, with a base year and four option years, for a total of $550,000.
The purpose of this Special Notice is to notify the public of the VA's intent to make a sole source award in accordance with FAR Part 6.302-1. Qualified sources may submit a quote or capabilities statement, which will be considered but will not bind the agency. The estimated award date is on or before October 1, 2024, and responses must be submitted via email to the Contract Specialist, Melissa Everett, by 5:00 PM on Friday, September 6, 2024. The agency will not reimburse any costs associated with providing or requesting information in response to this Special Notice.
Notice text
Page 2 of 2
This is not a solicitation for quotes.
This is a Special Notice. The purpose of this Special Notice is to provide notification of the Department of Veterans Affairs (VA) intent of contract action to make a sole source award in accordance with FAR Part 6.302-1.
Special Notice of Contract Action: Network Contracting Office (NCO) 8 intends to issue a sole source, firm fixed price contract with a base year and four option years, using other than full and open competition, to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. Estimated value of this acquisition is approximately $110,000.00/year and $550,000/including base and option years. The estimated award date is on or before October 01, 2024.
Qualified sources may submit a quote (or capabilities statement) which shall be considered but shall in no way bind the agency. Reimbursement will not be made for any costs associated with providing or requesting information in response to this Special Notice.
Responses shall be submitted via email to Melissa.Everett@va.gov and received no later than 5:00 PM on Friday, September 6, 2024.
Files
| File | Type | Posted |
|---|---|---|
| 36C24824Q1585.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity